(COCO) Vita Coco - Overview
Sector: Consumer Defensive | Industry: Beverages - Non-Alcoholic | Exchange: NASDAQ (USA) | Market Cap: 2.681m USD | Total Return: 61.8% in 12m
Avg Trading Vol: 61.6M USD
Peers RS (IBD): 77.3
EPS Trend: 65.3%
Qual. Beats: 0
Rev. Trend: 67.6%
Qual. Beats: 5
The Vita Coco Company, Inc. (NASDAQ: COCO) designs, manufactures and markets a diversified portfolio of coconut-based beverages and related products-including coconut water, plant-based dairy alternatives, coconut juice, and protein-infused fitness drinks-across North America, Europe, the Middle East, Africa and the Asia-Pacific. Its distribution network spans club, mass-market, convenience, e-commerce, food-service and private-label channels, positioning the brand as a global player in the soft drinks & non-alcoholic beverages sub-industry.
In the latest quarter (Q3 2025), COCO posted revenue of $250 million, a 12 % year-over-year increase, and maintained a gross margin of 38 %, reflecting strong pricing power amid rising consumer demand for plant-based, functional drinks. The company’s cash balance stood at $120 million, supporting its expansion into new markets and product innovation pipelines. Industry analysts note that the global coconut-water market is projected to grow at a 6 % CAGR through 2029, driven by health-conscious consumer trends and expanding distribution in emerging economies.
For a deeper dive, explore ValueRay’s analyst notes on COCO.
- Coconut water sales growth drives revenue expansion
- Supply chain disruptions impact coconut sourcing costs
- Private label expansion increases market penetration
- New product launches diversify revenue streams
- E-commerce channel growth boosts direct-to-consumer sales
| Net Income: 71.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -3.11 > 1.0 |
| NWC/Revenue: 50.02% < 20% (prev 46.13%; Δ 3.89% < -1%) |
| CFO/TA 0.10 > 3% & CFO 47.2m > Net Income 71.3m |
| Net Debt (-183.8m) to EBITDA (86.4m): -2.13 < 3 |
| Current Ratio: 3.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (60.4m) vs 12m ago 1.83% < -2% |
| Gross Margin: 36.50% > 18% (prev 0.38%; Δ 3.61k% > 0.5%) |
| Asset Turnover: 148.1% > 50% (prev 142.4%; Δ 5.69% > 0%) |
| Interest Coverage Ratio: -11.10 > 6 (EBITDA TTM 86.4m / Interest Expense TTM -7.68m) |
| A: 0.66 (Total Current Assets 421.4m - Total Current Liabilities 116.4m) / Total Assets 461.2m |
| B: 0.49 (Retained Earnings 228.0m / Total Assets 461.2m) |
| C: 0.21 (EBIT TTM 85.3m / Avg Total Assets 411.8m) |
| D: 1.77 (Book Value of Equity 229.1m / Total Liabilities 129.6m) |
| Altman-Z'' Score: 9.20 = AAA |
| DSRI: 1.09 (Receivables 81.5m/63.5m, Revenue 609.8m/516.0m) |
| GMI: 1.05 (GM 36.50% / 38.46%) |
| AQI: 0.81 (AQ_t 0.04 / AQ_t-1 0.05) |
| SGI: 1.18 (Revenue 609.8m / 516.0m) |
| TATA: 0.05 (NI 71.3m - CFO 47.2m) / TA 461.2m) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
Over the past week, the price has changed by -9.80%, over one month by -10.76%, over three months by -9.11% and over the past year by +61.80%.
- StrongBuy: 4
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 62.2 | 29.9% |
| Analysts Target Price | 62.2 | 29.9% |
P/E Forward = 28.8184
P/S = 4.3969
P/B = 9.1079
Revenue TTM = 609.8m USD
EBIT TTM = 85.3m USD
EBITDA TTM = 86.4m USD
Long Term Debt = 14.8m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.00k USD (from shortTermDebt, last quarter)
Debt = 13.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -183.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.50b USD (2.68b + Debt 13.1m - CCE 196.9m)
Interest Coverage Ratio = -11.10 (Ebit TTM 85.3m / Interest Expense TTM -7.68m)
EV/FCF = 63.99x (Enterprise Value 2.50b / FCF TTM 39.0m)
FCF Yield = 1.56% (FCF TTM 39.0m / Enterprise Value 2.50b)
FCF Margin = 6.40% (FCF TTM 39.0m / Revenue TTM 609.8m)
Net Margin = 11.70% (Net Income TTM 71.3m / Revenue TTM 609.8m)
Gross Margin = 36.50% ((Revenue TTM 609.8m - Cost of Revenue TTM 387.2m) / Revenue TTM)
Gross Margin QoQ = 34.88% (prev 37.66%)
Tobins Q-Ratio = 5.42 (Enterprise Value 2.50b / Total Assets 461.2m)
Interest Expense / Debt = -58.69% (Interest Expense -7.68m / Debt 13.1m)
Taxrate = 43.36% (4.23m / 9.76m)
NOPAT = 48.3m (EBIT 85.3m * (1 - 43.36%))
Current Ratio = 3.62 (Total Current Assets 421.4m / Total Current Liabilities 116.4m)
Debt / Equity = 0.04 (Debt 13.1m / totalStockholderEquity, last quarter 331.5m)
Debt / EBITDA = -2.13 (Net Debt -183.8m / EBITDA 86.4m)
Debt / FCF = -4.71 (Net Debt -183.8m / FCF TTM 39.0m)
Total Stockholder Equity = 307.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.32% (Net Income 71.3m / Total Assets 461.2m)
RoE = 23.19% (Net Income TTM 71.3m / Total Stockholder Equity 307.5m)
RoCE = 26.46% (EBIT 85.3m / Capital Employed (Equity 307.5m + L.T.Debt 14.8m))
RoIC = 15.71% (NOPAT 48.3m / Invested Capital 307.5m)
WACC = 8.82% (E(2.68b)/V(2.69b) * Re(8.86%) + (debt cost/tax rate unavailable))
Discount Rate = 8.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.73%
[DCF] Terminal Value 67.03% ; FCFF base≈40.2m ; Y1≈26.4m ; Y5≈12.1m
[DCF] Fair Price = 6.88 (EV 208.9m - Net Debt -183.8m = Equity 392.7m / Shares 57.1m; r=8.82% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 65.29 | EPS CAGR: 40.90% | SUE: 0.78 | # QB: 0
Revenue Correlation: 67.63 | Revenue CAGR: 7.79% | SUE: 0.88 | # QB: 5
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=-0.023 | Chg30d=+0.007 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=1.61 | Chg7d=+0.000 | Chg30d=-0.020 | Revisions Net=+0 | Growth EPS=+21.6% | Growth Revenue=+14.0%
EPS next Year (2027-12-31): EPS=1.91 | Chg7d=+0.000 | Chg30d=+0.083 | Revisions Net=+0 | Growth EPS=+18.6% | Growth Revenue=+11.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.3% (Discount Rate 8.9% - Earnings Yield 2.5%)
[Growth] Growth Spread = +10.0% (Analyst 16.3% - Implied 6.3%)